(Q43756872)

English

ST1571, a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia: validating the promise of molecularly targeted therapy

scientific article

Statements

ST1571, a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia: validating the promise of molecularly targeted therapy (English)
1 August 2001
48 Suppl 1
S77-8

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit